MADRIGAL PHARMACEUTICALS, INC. Other Accrued Liabilities, Current
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Other Accrued Liabilities, Current of $52.46 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:OtherAccruedLiabilitiesCurrent · last filed 2026-07-30
- 2026-06-30: Other Accrued Liabilities, Current $52.46M.
- 2026-03-31: Other Accrued Liabilities, Current $36.99M.
- 2025-12-31: Other Accrued Liabilities, Current $33.74M.
- 2025-09-30: Other Accrued Liabilities, Current $20.94M.
| Period end | Other Accrued Liabilities, Current | Other Accrued Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $52.46M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $36.99M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $33.74M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $20.94M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $10.97M 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $13.11M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $6.64M 10-K · filed 2026-02-19 | $8.17M 10-K · filed 2025-02-26 |
| 2024-09-30 | $6.81M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $5.12M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $4.04M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $1.97M 10-K · filed 2025-02-26 | |
| 2023-09-30 | $1.23M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $1.60M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $2.00M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $767.00K 10-K · filed 2024-02-28 | |
| 2022-09-30 | $3.06M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $2.64M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $2.11M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $279.00K 10-K/A · filed 2023-03-03 | $3.52M 10-K · filed 2022-02-24 |
| 2021-09-30 | $5.51M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $8.95M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $4.32M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $4.16M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $2.43M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $4.97M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $4.22M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $3.29M 10-K · filed 2021-02-25 | $5.91M 10-K · filed 2020-02-26 |
| 2019-09-30 | $4.56M 10-Q · filed 2019-11-06 | |
| 2018-12-31 | $2.53M 10-K · filed 2020-02-26 | $3.59M 10-Q · filed 2019-11-06 |
| 2016-06-30 | $129.00K 10-Q · filed 2016-07-20 | |
| 2016-03-31 | $921.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $1.04M 10-Q · filed 2016-07-20 | |
| 2015-09-30 | $1.10M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $1.14M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $1.11M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $1.04M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $1.06M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $1.00M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $982.00K 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $996.00K 10-K · filed 2015-03-12 | |
| 2013-09-30 | $793.00K 10-Q · filed 2013-11-04 | |
| 2013-06-30 | $781.00K 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $609.00K 10-Q · filed 2013-04-30 | |
| 2012-12-31 | $856.00K 10-K · filed 2014-03-11 | |
| 2011-12-31 | $611.00K 10-K · filed 2013-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |